Target intelligence / Profile preview

Sodium-calcium exchanger 1 (NCX1) (NCX1)

Target
NCX1
Molecular classification
Transporter, Solute carrier family
01

Overview

The Sodium-calcium exchanger 1 (NCX1) is a critical electrogenic transporter located on the plasma membrane of sinoatrial node (SAN) cells, where it plays a pivotal role in cardiac pacemaking (UniProt P32418; PubMed 15618538). It functions by exchanging three extracellular sodium ions for one intracellular calcium ion, or vice versa, depending on the electrochemical gradient (UniProt P32418). In the context of the SAN, NCX1 is the primary link between the calcium clock and the membrane clock, as it generates an inward depolarizing current (INCX) in response to spontaneous diastolic calcium releases from the sarcoplasmic reticulum (PubMed 21685500). This current accelerates the late phase of diastolic depolarization, ensuring the timely firing of action potentials that dictate the heart rate (PubMed 15618538; StatPearls NBK541011). Dysregulation of NCX1 activity is associated with various cardiovascular conditions, including sinus node dysfunction, atrial fibrillation, and heart failure (PubMed 21685500). While no NCX-specific inhibitors are currently in widespread clinical use, experimental compounds like SEA0400 and KB-R7943 are being studied for their potential to treat arrhythmias by modulating calcium handling (PubChem CID 119541). Additionally, drugs like digoxin indirectly influence NCX1 activity by altering the sodium gradient across the cell membrane (StatPearls NBK556025).

Other names
SLC8A1Solute carrier family 8 member 1Na+/Ca2+ exchanger 1Sodium/calcium exchanger 1NCX
02

Mechanism of action

Inhibition of the sodium-calcium exchange process to modulate intracellular calcium concentrations and the resulting electrogenic current.

03

Biological functions

Cardiac pacemakingCalcium homeostasisExcitation-contraction couplingDiastolic depolarization
04

Disease associations

ArrhythmiaHeart failureSinus node dysfunctionAtrial fibrillationIschemia-reperfusion injury
05

Safety considerations

Pro-arrhythmic riskImpairment of cardiac contractility (negative inotropy)Intracellular calcium overloadPotential for heart block
06

Interacting drugs

SEA0400

5 more in the full profile.

07

Biomarkers

Heart rateIntracellular calcium transientsNCX1 expression levelsElectrocardiogram (ECG) parameters

Beyond the preview

Go deeper on Sodium-calcium exchanger 1 (NCX1) (NCX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-calcium exchanger 1 (NCX1) (NCX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call